Merck (MRK) PT Raised to $86 at BofA Securities
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $150.91 --0%
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 30
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 30
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Merck (NYSE: MRK) to $86.00 (from $85.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rubrik Inc (RBRK) PT Raised to $139 at Baird
- Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Approved in Japan for Subcutaneous Administration for All KEYTRUDA® (pembrolizumab) Indications Approved in Japan
- Rockhopper Exploration Plc. (RKH:LN) (RCKHF) PT Raised to GBP1.35 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
